These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 28848007

  • 1. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
    Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848007
    [Abstract] [Full Text] [Related]

  • 2. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms.
    Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5818-30. PubMed ID: 25049240
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
    Armijo LM, Wawrzyniec SJ, Kopciuch M, Brandt YI, Rivera AC, Withers NJ, Cook NC, Huber DL, Monson TC, Smyth HDC, Osiński M.
    J Nanobiotechnology; 2020 Feb 18; 18(1):35. PubMed ID: 32070354
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.
    de Lacerda Coriolano D, de Souza JB, Bueno EV, Medeiros SMFRDS, Cavalcanti IDL, Cavalcanti IMF.
    Braz J Microbiol; 2021 Mar 18; 52(1):267-278. PubMed ID: 33231865
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by Pseudomonas aeruginosa isolates of pus samples in vitro.
    Salman M, Rizwana R, Khan H, Munir I, Hamayun M, Iqbal A, Rehman A, Amin K, Ahmed G, Khan M, Khan A, Amin FU.
    Artif Cells Nanomed Biotechnol; 2019 Dec 18; 47(1):2465-2472. PubMed ID: 31187657
    [Abstract] [Full Text] [Related]

  • 8. Triclosan Is an Aminoglycoside Adjuvant for Eradication of Pseudomonas aeruginosa Biofilms.
    Maiden MM, Hunt AMA, Zachos MP, Gibson JA, Hurwitz ME, Mulks MH, Waters CM.
    Antimicrob Agents Chemother; 2018 Jun 18; 62(6):. PubMed ID: 29661867
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles.
    Markowska K, Grudniak AM, Krawczyk K, Wróbel I, Wolska KI.
    J Med Microbiol; 2014 Jun 18; 63(Pt 6):849-854. PubMed ID: 24623636
    [Abstract] [Full Text] [Related]

  • 12. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA.
    Antimicrob Agents Chemother; 2007 May 18; 51(5):1813-7. PubMed ID: 17353241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
    Yuan YG, Peng QL, Gurunathan S.
    Int J Mol Sci; 2017 Mar 06; 18(3):. PubMed ID: 28272303
    [Abstract] [Full Text] [Related]

  • 15. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
    Thellin O, Zorzi W, Jolois O, Elmoualij B, Duysens G, Cahay B, Streel B, Charif M, Bastin R, Heinen E, Quatresooz P.
    Int J Antimicrob Agents; 2015 Jul 06; 46(1):33-8. PubMed ID: 25963337
    [Abstract] [Full Text] [Related]

  • 16. Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates.
    Kamer AMA, El Maghraby GM, Shafik MM, Al-Madboly LA.
    BMC Microbiol; 2024 Jul 26; 24(1):277. PubMed ID: 39060955
    [Abstract] [Full Text] [Related]

  • 17. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M, Gutu AD, Hebert W, Wager JD, Yonker LM, O'Toole GA, Ausubel FM, Moskowitz SM, Joseph-McCarthy D.
    Antimicrob Agents Chemother; 2017 Dec 26; 61(12):. PubMed ID: 28923873
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
    Eckert R, Brady KM, Greenberg EP, Qi F, Yarbrough DK, He J, McHardy I, Anderson MH, Shi W.
    Antimicrob Agents Chemother; 2006 Nov 26; 50(11):3833-8. PubMed ID: 16940063
    [Abstract] [Full Text] [Related]

  • 19. Anti-biofilm activity of silver nanoparticles against different microorganisms.
    Martinez-Gutierrez F, Boegli L, Agostinho A, Sánchez EM, Bach H, Ruiz F, James G.
    Biofouling; 2013 Nov 26; 29(6):651-60. PubMed ID: 23731460
    [Abstract] [Full Text] [Related]

  • 20. The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa.
    Mahdiun F, Mansouri S, Khazaeli P, Mirzaei R.
    Microb Pathog; 2017 Jun 26; 107():129-135. PubMed ID: 28323149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.